Survivin promoter -31G/C polymorphism in oral cancer cell lines

  • Authors:
    • Salvatore de Maria
    • Lorenzo lo Muzio
    • Alessandra Braca
    • Paolo Rega
    • Amalia Cassano
    • Angela Vinella
    • Ruggiero Fumarulo
    • Rosario Serpico
    • Ernesto Farina
    • Vittoria Metafora
    • Giuseppe Pannone
    • Gian Pietro Ravagnan
    • Salvatore Metafora
    • Corrado Rubini
    • Maria Carteni
    • Maria Addolorata Mariggiò
  • View Affiliations

  • Published online on: July 5, 2011     https://doi.org/10.3892/ol.2011.358
  • Pages: 935-939
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Survivin (SVV) is a protein that belongs to the inhibitor of apoptosis proteins (IAP) family and is involved in the G2/M phase progression of the cell cycle as a spindle‑associated molecule. The biological features of this protein are well documented and its activity appears to be involved in mitochondria-dependent and -independent antiapoptotic pathways. Overexpression of SVV at the transcriptional and translational level has been associated with cancer, a multifactorial disorder in which the occurrence of a -31G to C polymorphism in the promoter region may significantly contribute to the development of this pathology. To verify this hypothesis, the occurrence of a single nucleotide polymorphism (SNP) in cis-acting cell cycle-dependent elements (CDEs) and in cell cycle homology regions (CHRs) of the survivin TATA-less promoter was investigated. A total of 23 oral squamous cell carcinoma (OSCC) cell lines and normal epithelium-derived normal human epidermal keratinocyte (NHEK) cell lines were analyzed by RFLP and direct DNA sequencing of their promoter region. Furthermore, survivin expression at the transcriptional and translational levels was evaluated in these cells by RT-PCR and Western blotting, respectively. The findings indicate that the presence of a G or C allele is not directly correlated to survivin expression, at the mRNA or at the protein level, at least in the OSCC lines analyzed in this study.

Related Articles

Journal Cover

September-October 2011
Volume 2 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
de Maria S, lo Muzio L, Braca A, Rega P, Cassano A, Vinella A, Fumarulo R, Serpico R, Farina E, Metafora V, Metafora V, et al: Survivin promoter -31G/C polymorphism in oral cancer cell lines. Oncol Lett 2: 935-939, 2011
APA
de Maria, S., lo Muzio, L., Braca, A., Rega, P., Cassano, A., Vinella, A. ... Mariggiò, M. (2011). Survivin promoter -31G/C polymorphism in oral cancer cell lines. Oncology Letters, 2, 935-939. https://doi.org/10.3892/ol.2011.358
MLA
de Maria, S., lo Muzio, L., Braca, A., Rega, P., Cassano, A., Vinella, A., Fumarulo, R., Serpico, R., Farina, E., Metafora, V., Pannone, G., Ravagnan, G., Metafora, S., Rubini, C., Carteni, M., Mariggiò, M."Survivin promoter -31G/C polymorphism in oral cancer cell lines". Oncology Letters 2.5 (2011): 935-939.
Chicago
de Maria, S., lo Muzio, L., Braca, A., Rega, P., Cassano, A., Vinella, A., Fumarulo, R., Serpico, R., Farina, E., Metafora, V., Pannone, G., Ravagnan, G., Metafora, S., Rubini, C., Carteni, M., Mariggiò, M."Survivin promoter -31G/C polymorphism in oral cancer cell lines". Oncology Letters 2, no. 5 (2011): 935-939. https://doi.org/10.3892/ol.2011.358